CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19,851 enrolled
Drug / intervention
Mailed in-home high-risk HPV testing kit +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02005510
NCT02005510N/ACompleted
CompareCT.gov

Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women

University of Washington·interventional·Posted Dec 9, 2013·Updated Sep 16, 2020

In Brief

A clinical study evaluating Mailed in-home high-risk HPV testing kit and Usual care for Cervical Cancer. Completed, enrolled 19,851 participants across 1 site.

Detailed Summary

The purpose of this trial is to determine whether mailing in-home human papillomavirus (HPV) screening kits is effective in increasing uptake of cervical cancer screening and early detection and treatment of cervical neoplasia in underscreened women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Cancer
CountriesUnited States
CollaboratorsKaiser Permanente, University of Texas Southwestern Medical Center, National Cancer Institute (NCI), University of California, Davis

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 9, 2013
Enrollment StartFeb 1, 2014
Primary CompletionFeb 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 12.6 years ago

Interventions

Mailed in-home high-risk HPV testing kitbehavioral

Usual careother